Similarly, IL17-RA, IL-12/IL-23, or TNF inhibition treatments, were found to mainly affect the expression of IL-17 dependent genes, which further confirmed the hypothesis that IL-17 -stimulated KCs were key drivers of psoriasis (19, 74). The gene discussed is IL37; the disease is psoriasis.